Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The efficacy and safety of acetyl-l-carnitine (500 mg three times a day) versus methylcobalamin (0.5 mg three times a day) to treat diabetic peripheral neuropathy was assessed in a Chinese multicentre, randomised, parallel-group, double-blind, double-dummy, positive-controlled, non-inferiority phase II clinical trial
WADA Classification: May be listed as a prohibited substance by the World Anti-Doping Agency (WADA)
An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus
Hypertension-mediated pathological cardiac remodeling Zheng et al
doi:10.17925/ee.2018.14.1.24
US$ 25.94
US$ 24.54
US$ 28.67
US$ 26.53
US$ 20.43
